2-(((3aR,4S,6R,6aS)-6-(7-(((1R,2S)-2-(3,4-Difluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yl)oxy)ethanol
≥95%
- Product Code: 85713
CAS:
274693-26-4
| Molecular Weight: | 562.63 g./mol | Molecular Formula: | C₂₆H₃₂F₂N₆O₄S |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD23160137 | |
| Melting Point: | Boiling Point: | 759.1±70.0°C at 760 mmHg | |
| Density: | Storage Condition: | -20°C, protected from light and stored in an inert gas |
Product Description:
This compound is primarily utilized in the field of medicinal chemistry, particularly in the development of targeted therapies. It functions as a potent inhibitor of specific enzymes or receptors involved in disease pathways, making it a valuable candidate for drug discovery. Its structure is designed to interact with biological targets, such as kinases or other proteins, to modulate their activity and potentially treat conditions like cancer, inflammatory diseases, or cardiovascular disorders. Researchers explore its efficacy in preclinical studies to assess its therapeutic potential, optimize its pharmacokinetic properties, and evaluate its safety profile for future clinical applications.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 1.000 | 10-20 days | £87.73 |
+
-
|
| 5.000 | 10-20 days | £266.04 |
+
-
|
| 10.000 | 10-20 days | £445.78 |
+
-
|
| 25.000 | 10-20 days | £875.89 |
+
-
|
2-(((3aR,4S,6R,6aS)-6-(7-(((1R,2S)-2-(3,4-Difluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yl)oxy)ethanol
This compound is primarily utilized in the field of medicinal chemistry, particularly in the development of targeted therapies. It functions as a potent inhibitor of specific enzymes or receptors involved in disease pathways, making it a valuable candidate for drug discovery. Its structure is designed to interact with biological targets, such as kinases or other proteins, to modulate their activity and potentially treat conditions like cancer, inflammatory diseases, or cardiovascular disorders. Researchers explore its efficacy in preclinical studies to assess its therapeutic potential, optimize its pharmacokinetic properties, and evaluate its safety profile for future clinical applications.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
£0.00
£0.00
Total :